Skin Care Carries J&J Consumer Biz. In Quarter Marred By OTC Drug Recall
This article was originally published in The Rose Sheet
Executive Summary
Johnson & Johnson's skin-care franchise helped offset weak oral-care sales and hampered over-the-counter and nutritionals business associated with a recall of Motrin, Tylenol and other products in the firm's fiscal 2010 first quarter
You may also be interested in...
FDA Flags J&J For Inadequate Oversight Of Consumer Devices
Though the firm claims to have come a long way in improving management of OTC pharma quality control since its 2009/2010 recalls, a May 22 warning letter regarding post-market monitoring and pre-market notifications for K-Y moisturizers suggests consumer devices are not getting the same level of attention.
J&J Extends Leading Skin-Care Brands With Kits Featuring Cytomimic
Capitalizing on momentum in its skin-care business, Johnson & Johnson is introducing new Cytomimic technology to its Aveeno, Neutrogena and RoC brands with dual-product kits for anti-aging needs around the clock
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program